Description

Dr. Manisha Juthani, Connecticut's Public Health Commissioner, explains why providers may not be prescribing COVID-19 therapeutics; ASTHO publishes a new report to help public health leaders maximize the benefits of COVID-19 therapies; Latoya Sahadeo, ASTHO's Director of Leadership Development, says the organization is accepting applications for the second class of scholars in the Diverse Executives Leading in Public Health program; and there's still time to register for ASTHO's Public Health TechXpo starting tomorrow online.

ASTHO Brief: Maximizing the Benefit of COVID-19 Therapeutics: Considerations for State Public Health Officials

ASTHO Webpage: Diverse Executives Leading in Public Health

ASTHO Website: Public Health TechXpo

ASTHO News Release: Getting Ahead of the Next Pandemic, Leaders Convene to Identify Solutions to Transform U.S. Health Data

ASTHO TechXpo Sponsor: RTI International

ASTHO TechXpo Sponsor: Deloitte

ASTHO TechXpo Sponsor: Optum

ASTHO TechXpo Sponsor: RSM